📊 PMI Key Takeaways
Is Picard Medical, Inc. (PMI) a Good Investment?
Picard Medical exhibits severe operational distress with negative gross margins (-4.1%), catastrophic losses ($27M net loss on $4.9M revenue), and unsustainable cash burn ($15.7M annually). With only $7.5M cash and a current ratio of 1.11x, the company faces critical liquidity pressure within 6-12 months absent significant operational improvement or capital infusion. The negative gross margin indicates fundamental business model dysfunction rather than temporary startup scaling challenges.
Picard Medical, Inc. Key Strengths (PMI)
- Revenue growth of 12.5% YoY demonstrates market demand for product
- Cash position of $7.5M provides short-term runway for turnaround efforts
- Zero long-term debt eliminates financial leverage burden
PMI Stock Risks: Picard Medical, Inc. Investment Risks
- Negative gross margin of -4.1% reveals fundamental cost structure or pricing dysfunction
- Annual cash burn of $15.7M against $7.5M cash creates existential solvency risk within 6 months
- Net margin of -546.6% and operating margin of -268.4% indicate company is unsustainable in current form
- Quick ratio of 0.72x below 1.0 threshold signals potential inability to meet short-term obligations
- Zero insider Form 4 filings in 90 days suggests management lacks confidence in near-term recovery
Key Metrics to Watch
- Gross margin trajectory (critical inflection point for viability)
- Monthly cash burn rate and runway remaining
- Revenue growth sustainability and customer retention rates
Picard Medical, Inc. (PMI) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Picard Medical, Inc. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
PMI Profit Margin, ROE & Profitability Analysis
PMI vs Healthcare Sector: How Picard Medical, Inc. Compares
How Picard Medical, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Picard Medical, Inc. Stock Overvalued? PMI Valuation Analysis 2026
Based on fundamental analysis, Picard Medical, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Picard Medical, Inc. Balance Sheet: PMI Debt, Cash & Liquidity
PMI Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Picard Medical, Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-2.99 indicates the company is currently unprofitable.
PMI Revenue Growth, EPS Growth & YoY Performance
PMI Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $620.0K | -$5.6M | $-0.10 |
| Q3 2025 | $881.0K | -$2.0M | $-0.19 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Picard Medical, Inc. Dividends, Buybacks & Capital Allocation
PMI SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Picard Medical, Inc. (CIK: 0002030617)
📋 Recent SEC Filings
❓ Frequently Asked Questions about PMI
What is the AI rating for PMI?
Picard Medical, Inc. (PMI) has an AI grade of D with 95% confidence, based on fundamental analysis of SEC EDGAR filings.
What are PMI's key strengths?
Claude: Revenue growth of 12.5% YoY demonstrates market demand for product. Cash position of $7.5M provides short-term runway for turnaround efforts.
What are the risks of investing in PMI?
Claude: Negative gross margin of -4.1% reveals fundamental cost structure or pricing dysfunction. Annual cash burn of $15.7M against $7.5M cash creates existential solvency risk within 6 months.
What is PMI's revenue and growth?
Picard Medical, Inc. reported revenue of $4.9M.
Does PMI pay dividends?
Picard Medical, Inc. does not currently pay dividends.
Where can I find PMI SEC filings?
Official SEC filings for Picard Medical, Inc. (CIK: 0002030617) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is PMI's EPS?
Picard Medical, Inc. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is PMI's fundamental grade?
Based on our AI fundamental analysis in June 2026, Picard Medical, Inc. has a D grade with 95% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is PMI stock overvalued or undervalued?
Valuation metrics for PMI: ROE of -712.6% (sector avg: 15%), net margin of -546.6% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is PMI's AI grade for 2026?
Our dual AI analysis gives Picard Medical, Inc. a combined D grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is PMI's free cash flow?
Picard Medical, Inc.'s operating cash flow is $-15.7M, with capital expenditures of N/A. FCF margin is -317.3%.
How does PMI compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -546.6% (avg: 12%), ROE -712.6% (avg: 15%), current ratio 1.11 (avg: 2).